Dr. Matthew Gordon Rein, MD

Dr. Rein practices at Duke Regional Hospital in Durham, North Carolina, part of Duke University.

Dr. Rein's NPI, 1134393200, was assigned on April 18, 2008. Dr. Rein holds North Carolina license 2011-01335.

Dr. Rein's primary practice is Duke Regional Hospital, at 3643 N Roxboro Street, Durham, NC 27704 in Durham County. The practice phone is (919) 470-4000.

Dr. Rein's primary practice is Duke Regional Hospital in Durham, North Carolina, part of Duke University. Dr. Rein is also affiliated with Duke University Hospital. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Rein to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rein practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Rein's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Rein is licensed in North Carolina.

CMS data shows 591 Medicare services from Dr. Rein across 10 procedure codes in 2024, for 237 Medicare patients. Medicare paid $42,775 for them.

CMS counts 237 Medicare patients who saw Dr. Rein in 2024. The largest group is 65 to 74, with 130 patients. 73% of them have high cholesterol, and 65% have high blood pressure. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rein's median patient age at 69, with 54% women.

In 2024, Dr. Rein wrote 524 Medicare Part D claims for 239 patients. 77% of them were for generic drugs. CMS names the drug for 402 of them, across 12 drugs with 11 or more claims each, at $93,755 in total drug cost. In 2023, CMS named 322 claims across 14 drugs.

Dr. Rein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rein as offering telehealth. CMS counts 73 procedures of colonoscopy by Dr. Rein, more than 72% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Rein in 2018. 2018 was the busiest year, with 2. Dr. Rein's most frequent co-authors are Edward F. Hendershot, MD, Cynthia A. Moylan, MD and Jessica Leigh Seidelman, MD.

CMS Open Payments shows 50 general payments to Dr. Rein from 10 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 57% of the total. Boston Scientific Corporation paid the most, $1,148.